Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2020.06.10.20127563: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Exposures: Sex was collected as a binary variable (male/female). Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:However, again, while it listed the specific LTCs associated with increased risk, such as ischaemic heart disease and diabetes, it did not describe which patterns of …
SciScore for 10.1101/2020.06.10.20127563: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Exposures: Sex was collected as a binary variable (male/female). Table 2: Resources
No key resources detected.
Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:However, again, while it listed the specific LTCs associated with increased risk, such as ischaemic heart disease and diabetes, it did not describe which patterns of multimorbidity were associated with the highest risk.(13) Strengths and limitations: As a large prospective cohort with rich demographic, lifestyle, health, and anthropometric data linked to COVID-19 test results, UK Biobank provides a valuable opportunity to examine the predictors for COVID-19.(34, 35) In particular, the rich data allowed examination of the risk of a positive COVID-19 test in those with multimorbidity and the influence of a range of known sociodemographic, lifestyle and physiological risk factors for COVID-19. However, our study has a number of limitations. Firstly, the proportion of UK Biobank participants with COVID-19 test data is currently low (1.05%) which resulted in wide confidence intervals for groups with few participants. Secondly, the denominator for the test group included all those who had a negative test result as well as those who were not tested at all. At the time for which COVID-19 test data are available, the strategy in the UK had been to only test those in hospital (emergency department and inpatient) settings. This means the positive COVID-19 participants are likely to have had sufficiently severe clinical signs and symptoms to justify hospital assessment and those with COVID-19 but with mild symptoms are less likely to have been tested. Our results are therefore likely to ...
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
